Passage Bio (PASG) Stock: Buy, Sell, or Hold?
PASG - Passage Bio, Inc. Common Stock
$3.51
-0.08 (-2.23%)
▼
5d:
-2.5%
30d:
-29.8%
90d:
-28.95%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 09, 2026
17d
Get Alerted When PASG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PASG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PASG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PASG is currently trading at $3.51, which is considered oversold relative to its 30-day fair value range of $3.71 to $4.81.
Technical Outlook: Technically, PASG is in a downtrend. Immediate support is located at $3.37, while resistance sits at $4.55.
Market Sentiment: PASG scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.50 (+341.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PASG is in a downtrend. Immediate support is located at $3.37, while resistance sits at $4.55.
Market Sentiment: PASG scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.50 (+341.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.71 -
$4.81
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 341.6% below Wall St target ($15.50)
- CAUTION: Bottoming setup, but lagging the sector by 10% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.71 -
$4.81
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.37
Resistance Level
$4.55
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.30
Wall Street Target
$15.50
(+341.6%)
Share & Embed Analysis
Last updated: October 22, 2026 6:27 PM ET
Data refreshes hourly during market hours. Next update: 7:27 PM
Data refreshes hourly during market hours. Next update: 7:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PASG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 56 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 49 HOLD |
|
TRVI
Trevi Therapeutics Inc |
STRONG BUY
11 analysts |
$28 | 69 BUY |